Does DABIGATRAN ETEXILATE Cause Hyperkalaemia? 117 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 117 reports of Hyperkalaemia have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 0.3% of all adverse event reports for DABIGATRAN ETEXILATE.
117
Reports of Hyperkalaemia with DABIGATRAN ETEXILATE
0.3%
of all DABIGATRAN ETEXILATE reports
34
Deaths
97
Hospitalizations
How Dangerous Is Hyperkalaemia From DABIGATRAN ETEXILATE?
Of the 117 reports, 34 (29.1%) resulted in death, 97 (82.9%) required hospitalization, and 22 (18.8%) were considered life-threatening.
Is Hyperkalaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 117 reports have been filed with the FAERS database.
What Other Side Effects Does DABIGATRAN ETEXILATE Cause?
Gastrointestinal haemorrhage (4,081)
Cerebrovascular accident (2,175)
Fall (1,786)
Ischaemic stroke (1,581)
Anaemia (1,412)
Haemorrhage (1,324)
Death (1,025)
Rectal haemorrhage (964)
Cerebral haemorrhage (946)
Upper gastrointestinal haemorrhage (861)
What Other Drugs Cause Hyperkalaemia?
METFORMIN (2,565)
SPIRONOLACTONE (2,518)
FUROSEMIDE (2,035)
RAMIPRIL (1,383)
SACUBITRIL\VALSARTAN (1,192)
SULFAMETHOXAZOLE\TRIMETHOPRIM (1,036)
LISINOPRIL (948)
POTASSIUM (944)
BISOPROLOL (850)
TACROLIMUS (713)
Which DABIGATRAN ETEXILATE Alternatives Have Lower Hyperkalaemia Risk?
DABIGATRAN ETEXILATE vs DABRAFENIB
DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB
DABIGATRAN ETEXILATE vs DACARBAZINE
DABIGATRAN ETEXILATE vs DACLATASVIR
DABIGATRAN ETEXILATE vs DACLIZUMAB